Barclays Downgrades HealthSouth (HLS) to Underweight
Tweet
Share
E-mailGet Alerts HLS Hot Sheet
Price: $49.41 --0%
Rating Summary:
8 Buy, 6 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 9
Rating Summary:
8 Buy, 6 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 9
Join SI Premium – FREE
Barclays downgraded HealthSouth (NYSE: HLS) from Equalweight to Underweight with a price target of $42.00 (from $45.00).
For an analyst ratings summary and ratings history on HealthSouth click here. For more ratings news on HealthSouth click here.
Shares of HealthSouth closed at $39.56 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TechnipFMC (FTI) PT Raised to $30 at BTIG
- Berenberg Starts Lloyds TSB Group (LYG) at Hold, 'shares are fairly valued'
- Amazon.com (AMZN) PT Raised to $215 at UBS
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
